MBX Biosciences Inc. Comm...

NASDAQ: MBX · Real-Time Price · USD
14.74
1.53 (11.58%)
At close: Aug 15, 2025, 3:59 PM
14.92
1.22%
After-hours: Aug 15, 2025, 07:58 PM EDT

MBX Biosciences Common Stock Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Net Income
-19.41M -23.88M -15.59M -18.14M -15.86M -12.34M -8.84M -10.16M -7.61M
Depreciation & Amortization
-979K 77K 58K 75K 63K 48K 41K 40K 39K
Stock-Based Compensation
1.94M 1.84M 1.49M 1.19M n/a n/a 1.02M 596K n/a
Other Working Capital
-1.09M 2.16M -1.27M 542K 1.44M -40K -2.55M 1.53M -529K
Other Non-Cash Items
101K -1.31M -1.37M -560K 505K 1.15M -506K 9K 86K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
918K 600K -627K 2.77M 2.02M 434K -2.86M 1.79M 102K
Operating Cash Flow
-17.43M -22.68M -16.04M -14.66M -13.27M -10.71M -11.15M -7.73M -7.38M
Capital Expenditures
-707K -30K -92K -57K -452K -273K -55K -22K -31K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-47.43M -58.89M -87.5M -127.73M -15.69M -8.55M -33.9M -20.58M n/a
Sales Maturities Of Investments
73.12M 57.15M 20.25M 27M 8.25M 24.25M 5M 2M 20M
Other Investing Acitivies
1M 5M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
25.99M 3.23M -67.34M -100.79M -7.89M 15.43M -28.95M -18.61M 19.97M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a -1.71M n/a n/a n/a 19K n/a n/a
Financial Cash Flow
1.33M 4K -132K 235.81M -1.76M 183K 19K 68.5M 634K
Net Cash Flow
9.88M -19.45M -83.51M 120.36M -22.92M 35.42M -40.08M 42.16M n/a
Free Cash Flow
-18.14M -22.71M -16.13M -14.72M -13.72M -10.98M -11.2M -7.75M -7.41M